{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:25:23Z","timestamp":1781479523255,"version":"3.54.1"},"reference-count":186,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.577303","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T06:57:30Z","timestamp":1600325850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia"],"prefix":"10.3389","volume":"11","author":[{"given":"Charles","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","article-title":"The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance","volume":"13","author":"Peyrani","year":"2019","journal-title":"Expert Rev Respir Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e20180374","DOI":"10.1590\/1806-3713\/e20180374","article-title":"Mortality and costs of pneumococcal pneumonia in adults: a cross-sectional study","volume":"45","author":"Michelin","year":"2019","journal-title":"J Bras Pneumol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/arh.2017.12.03","article-title":"Epidemiology, pathophysiology, and microbiology of community-acquired pneumonia","volume":"2","author":"Cill\u00f3niz","year":"2018","journal-title":"Ann Res Hosp."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","volume":"37","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17476348.2019.1555040","article-title":"Epidemiology of lower respiratory tract infections in adults","volume":"13","author":"Feldman","year":"2019","journal-title":"Expert Rev Respir Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"GBD","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/cid\/cix549","article-title":"Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus","volume":"65","author":"Musher","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00038-017-1007-0","article-title":"Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study","volume":"63","author":"GBD","year":"2018","journal-title":"Int J Public Health."},{"key":"B9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1590\/1980-5497201700050014","article-title":"Burden of disease by lower respiratory tract infections in Brazil, 1990 to 2015: estimates of the Global Burden of Disease 2015 study","volume":"20","author":"Corr\u00eaa","year":"2017","journal-title":"Rev Bras Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","article-title":"Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review","volume":"137","author":"Torres","year":"2018","journal-title":"Respir Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/arh.2018.04.02","article-title":"Early, short and long-term mortality in community-acquired pneumonia","volume":"2","author":"V\u00ecasus","year":"2018","journal-title":"Ann Res Hosp."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.chest.2019.06.040","article-title":"Community-acquired pneumonia patients at risk for early and long-term cardiovascular events are identified by cardiac biomarkers","volume":"156","author":"Men\u00e9ndez","year":"2019","journal-title":"Chest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/joim.12875","article-title":"Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia","volume":"285","author":"Feldman","year":"2019","journal-title":"J Intern Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13054-019-2579-2","article-title":"Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study","volume":"23","author":"Wu","year":"2019","journal-title":"Crit Care."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1701794","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Warren-Gash","year":"2018","journal-title":"Eur Respir J."},{"key":"B17","unstructured":"Abstract 11296: bacterial pneumonia compared to viral pneumonia is associated with a higher risk of future major adverse cardiovascular eventsA11296\n            SteinerGS\n            KnightS\n            MillerRR\n            BairTL\n            HorneBD\n            LopansriBK\n          Circulation.1382018"},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/MCP.0000000000000466","article-title":"Pneumonia as a systemic illness","volume":"24","author":"Feldman","year":"2018","journal-title":"Curr Opin Pulm Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/resp.13233","article-title":"Pneumonia as a cardiovascular disease","volume":"23","author":"Restrepo","year":"2018","journal-title":"Respirology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1111\/crj.12791","article-title":"Acute cardiac events in severe community-acquired pneumonia: a multicenter study","volume":"12","author":"C\u00eclli","year":"2018","journal-title":"Clin Respir J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/jcm9020414","article-title":"Cardiovascular events after community-acquired pneumonia: a global perspective with systematic review and meta-analysis of observational studies","volume":"9","author":"Tralh\u00e3o","year":"2020","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/JMISR.JMISR_4_19","article-title":"Cardiac dysfunction in patients with community-acquired pneumonia","volume":"2","author":"Shaheen","year":"2019","journal-title":"J Med Sci Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/jcm9020549","article-title":"Biomarkers in community-acquired pneumonia (cardiac and non-cardiac)","volume":"9","author":"M\u00e9ndez","year":"2020","journal-title":"J Clin Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajem.2018.05.061","article-title":"The risk stratification in community-acquired pneumonia","volume":"37","author":"\u00d6zlek","year":"2019","journal-title":"Am J Emerg Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2019.01.012","article-title":"Performance of the CHA2DS2\u2212VASc score in predicting new onset atrial fibrillation during hospitalization for community-acquired pneumonia","volume":"62","author":"Pieralli","year":"2019","journal-title":"Eur J Intern Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1086\/518849","article-title":"The association between pneumococcal pneumonia and acute cardiac events","volume":"45","author":"Musher","year":"2007","journal-title":"Clin Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/INF.0000000000002527","article-title":"Pneumococcal pneumonia resembling acute myocardial infarction in an adolescent male","volume":"39","author":"Chiong","year":"2020","journal-title":"Pediatr Infect Dis J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E1147","DOI":"10.3390\/ijms19041147","article-title":"Multifaceted role of pneumolysin in the pathogenesis of myocardial injury in community-acquired pneumonia","volume":"19","author":"Anderson","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/HCO.0000000000000604","article-title":"Cardiovascular complications following pneumonia: focus on pneumococcus and heart failure","volume":"34","author":"Bartlett","year":"2019","journal-title":"Curr Opin Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"OA3306","DOI":"10.1183\/13993003.congress-2019.OA3306","article-title":"Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events","volume":"54","author":"Borsa","year":"2019","journal-title":"Eur Respir J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0204032","DOI":"10.1371\/journal.pone.0204032","article-title":"Severity and properties of cardiac damage caused by Streptococcus pneumoniae are strain dependent","volume":"13","author":"Shenoy","year":"2018","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/cts.2018.51","article-title":"Cardiac injury due to Streptococcus pneumoniae invasion during severe pneumococcal pneumonia in a novel nonhuman primate model","volume":"2","author":"Reyes","year":"2018","journal-title":"J Clin Transl Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.3390\/ijms20174220","article-title":"Animal models of Pneumococcal pneumonia","volume":"20","author":"Borsa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1004836","DOI":"10.1371\/journal.ppat.1004836","article-title":"Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection","volume":"11","author":"Alhamdi","year":"2015","journal-title":"PLoS Pathog."},{"key":"B35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/MCP.0000000000000674","article-title":"Pneumococcal virulence factors in community-acquired pneumonia","volume":"26","author":"Feldman","year":"2020","journal-title":"Curr Opin Pulm Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/blood-2007-05-088500","article-title":"Historical review: megakaryopoiesis and thrombopoiesis","volume":"111","author":"Kaushansky","year":"2008","journal-title":"Blood."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"Mason","year":"2007","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MOH.0000000000000526","article-title":"Altered functions of platelets during aging","volume":"26","author":"Montenont","year":"2019","journal-title":"Curr Opin Hematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4049\/jimmunol.1700885","article-title":"Granzyme A in human platelets regulates the synthesis of proinflammatory cytokines by monocytes in aging","volume":"200","author":"Campbell","year":"2018","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2015.00082","article-title":"Platelets and infections - complex interactions with bacteria","volume":"6","author":"Hamzeh-Cognasse","year":"2015","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12865-015-0092-1","article-title":"Human platelets and their capacity of binding viruses: meaning and challenges?","volume":"16","author":"Chabert","year":"2015","journal-title":"BMC Immunol."},{"key":"B42","first-page":"65","article-title":"Platelets: essential components of the immune system","volume":"16","author":"Ali","year":"2015","journal-title":"Curr Trends Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1753425918789255","article-title":"Start a fire, kill the bug: the role of platelets in inflammation and infection","volume":"24","author":"Deppermann","year":"2018","journal-title":"Innate Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3389\/fimmu.2019.02204","article-title":"The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"E1730","DOI":"10.3390\/ijms20071730","article-title":"Understanding platelets in infectious and allergic lung diseases","volume":"20","author":"Gomez-Casado","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41577-019-0202-z","article-title":"Patrolling the vascular borders: platelets in immunity to infection and cancer","volume":"19","author":"Gaertner","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1055\/s-0040-1708827","article-title":"A champion of host defense: a generic large-scale cause for platelet dysfunction and depletion in infection","volume":"46","author":"Page","year":"2020","journal-title":"Semin Thromb Hemost."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J Thromb Haemost."},{"key":"B49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1574-695X.2012.00945.x","article-title":"Human platelets efficiently kill IgG-opsonized E. coli","volume":"65","author":"Riaz","year":"2012","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1111\/jth.13495","article-title":"Platelet-borne complement proteins and their role in platelet-bacteria interactions","volume":"14","author":"Arbesu","year":"2016","journal-title":"J Thromb Haemost."},{"key":"B51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bjh.14653","article-title":"Platelets: much more than bricks in a breached wall","volume":"178","author":"Mancuso","year":"2017","journal-title":"Br J Haematol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jinf.2017.09.013","article-title":"Review manuscript: mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia","volume":"75","author":"Anderson","year":"2017","journal-title":"J Infect."},{"key":"B54","doi-asserted-by":"publisher","first-page":"14542","DOI":"10.1074\/jbc.M114.623876","article-title":"Pneumococcal adhesins PavB and PspC are important for the interplay with human thrombospondin-1","volume":"290","author":"Binsker","year":"2015","journal-title":"J Biol Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/IAI.01573-08","article-title":"Streptococcus mitis phage-encoded adhesins mediate attachment to \u03b12-8-linked sialic acid residues on platelet membrane gangliosides","volume":"77","author":"Mitchell","year":"2009","journal-title":"Infect Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1073\/pnas.0435928100","article-title":"Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection","volume":"100","author":"Malley","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1023\/B:BIRY.0000009135.85883.65","article-title":"H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling","volume":"68","author":"Loiko","year":"2003","journal-title":"Biochemistry."},{"key":"B58","unstructured":"Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms491502\n            RedondoPC\n            SalidoGM\n            RosadoJA\n            ParienteJA\n          10.1016\/j.bcp.2003.09.03115037201Biochem Pharmacol.672004"},{"key":"B59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/09537104.2019.1615612","article-title":"Human platelets and megakaryocytes express defensin alpha 1","volume":"31","author":"Valle-Jim\u00e9nez","year":"2020","journal-title":"Platelets."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1002355","DOI":"10.1371\/journal.ppat.1002355","article-title":"Novel anti-bacterial activities of \u03b2-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation","volume":"7","author":"Kraemer","year":"2011","journal-title":"PLoS Pathog."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1038\/s41598-019-40216-2","article-title":"Proteolytic degradation of reduced human beta defensin 1 generates a novel antibiotic octapeptide","volume":"9","author":"Wendler","year":"2019","journal-title":"Sci Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.injury.2010.12.010","article-title":"Thrombocytes are effectors of the innate immune system releasing human beta defensin-3","volume":"42","author":"Tohidnezhad","year":"2011","journal-title":"Injury."},{"key":"B63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2012.00276","article-title":"Antimicrobial chemokines","volume":"3","author":"Yung","year":"2012","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1182\/blood.V124.21.4993.4993","article-title":"Determination of the microbicidal capacity of platelets by a biomonitoring system","volume":"124","author":"Stoldt","year":"2014","journal-title":"Blood."},{"key":"B65","unstructured":"LieffJ\n          Platelet Intelligence2014"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0205521","DOI":"10.1371\/journal.pone.0205521","article-title":"CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection","volume":"13","author":"Yue","year":"2018","journal-title":"PLoS ONE."},{"key":"B67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4161\/viru.1.5.12983","article-title":"Antimicrobial peptides: the ancient arm of the human immune system","volume":"1","author":"Wiesner","year":"2010","journal-title":"Virulence."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.bbamem.2018.06.004","article-title":"Bactericidal activity of amphipathic cationic antimicrobial peptides involves altering the membrane fluidity when interacting with the phospholipid bilayer","volume":"1860","author":"Omardien","year":"2018","journal-title":"Biochim Biophys Acta Biomembr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/14712598.2018.1448382","article-title":"Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations","volume":"18","author":"Tan","year":"2018","journal-title":"Expert Opin Biol Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"E145","DOI":"10.3390\/cells7100145","article-title":"Thymosin beta-4 and ciprofloxacin adjunctive therapy improves Pseudomonas aeruginosa-Induced keratitis","volume":"7","author":"Carion","year":"2018","journal-title":"Cells."},{"key":"B71","doi-asserted-by":"publisher","first-page":"102701","DOI":"10.1016\/j.dnarep.2019.102701","article-title":"Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: implications in DNA repair and immune responses","volume":"83","author":"Mandke","year":"2019","journal-title":"DNA Repair."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1055\/s-0037-1614175","article-title":"Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation","volume":"84","author":"Rouhiainen","year":"2000","journal-title":"Thromb Haemost."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3389\/fimmu.2017.01946","article-title":"From human megakaryocytes to platelets: effects of aspirin on high-mobility group box 1\/receptor for advanced glycation end products axis","volume":"8","author":"Mardente","year":"2018","journal-title":"Front Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fimmu.2016.00182","article-title":"Disruption of a regulatory network consisting of neutrophils and platelets fosters persisting inflammation in rheumatic diseases","volume":"7","author":"Maugeri","year":"2016","journal-title":"Front Immunol."},{"key":"B75","first-page":"3224","article-title":"Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations","volume":"9","author":"Subramanian","year":"2017","journal-title":"Am J Transl Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1189\/jlb.1212662","article-title":"The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis","volume":"93","author":"Yang","year":"2013","journal-title":"J Leukoc Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2119\/molmed.2011.00389","article-title":"Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)","volume":"18","author":"Yang","year":"2012","journal-title":"Mol Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbi.2014.06.199","article-title":"Identification of a functional interaction of HMGB1 with receptor for advanced glycation end-products in a model of neuropathic pain","volume":"42","author":"Allette","year":"2014","journal-title":"Brain Behav Immun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/jnc.14663","article-title":"High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches","volume":"151","author":"Paudel","year":"2019","journal-title":"J Neurochem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J Exp Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J Exp Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1989","DOI":"10.1038\/cddis.2015.233","article-title":"Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7","volume":"6","author":"Chatterjee","year":"2015","journal-title":"Cell Death Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"L342","DOI":"10.1152\/ajplung.00151.2012","article-title":"HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4","volume":"304","author":"Tadie","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1111\/jth.12710","article-title":"Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps","volume":"12","author":"Maugeri","year":"2014","journal-title":"J Thromb Haemost."},{"key":"B85","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/biot.200800362","article-title":"The blood platelets contribution to innate host defense - what they have learned from their big brothers","volume":"4","author":"Zander","year":"2009","journal-title":"Biotechnol J."},{"key":"B86","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/09533710022149395","article-title":"Generation of reactive oxygen species in blood platelets","volume":"13","author":"Wachowicz","year":"2002","journal-title":"Platelets."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1182\/blood-2005-03-1047","article-title":"Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIb\/beta3-integrin activation independent of the NO\/cGMP pathway","volume":"106","author":"Begonja","year":"2005","journal-title":"Blood."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1182\/bloodadvances.2018025569","article-title":"Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in mice","volume":"3","author":"Sonkar","year":"2019","journal-title":"Blood Adv."},{"key":"B89","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.4049\/jimmunol.178.10.6573","article-title":"Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling","volume":"178","author":"Fan","year":"2007","journal-title":"J Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/bloodadvances.2017011817","article-title":"Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice","volume":"2","author":"Zhou","year":"2018","journal-title":"Blood Adv."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2014-10-605261","article-title":"NOX2 is critical for heterotypic neutrophil-platelet interactions during vascular inflammation","volume":"126","author":"Kim","year":"2015","journal-title":"Blood."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1074\/jbc.RA117.000515","article-title":"Leukocyte integrin Mac-1 (CD11b\/CD18, \u03b1M\u03b22, CR3) acts as a functional receptor for platelet factor 4","volume":"293","author":"Lishko","year":"2018","journal-title":"J Biol Chem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","article-title":"Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients","volume":"127","author":"Claushuis","year":"2016","journal-title":"Blood."},{"key":"B94","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/infdis\/jiy541","article-title":"Thrombocytopenia impairs host defense against Burkholderia pseudomallei (melioidosis)","volume":"219","author":"Birnie","year":"2019","journal-title":"J Infect Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood.2019003442","article-title":"Platelets docking to VWF prevent leaks during leukocyte extravasation by stimulating Tie-2","volume":"136","author":"Braun","year":"2020","journal-title":"Blood."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4269\/ajtmh.18-0698","article-title":"Clinical utility of platelet count as a prognostic marker for melioidosis","volume":"100","author":"Kirby","year":"2019","journal-title":"Am J Trop Med Hyg."},{"key":"B97","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2119\/molmed.2012.00024","article-title":"Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas aeruginosa pneumonia in cystic fibrosis","volume":"18","author":"Entezari","year":"2012","journal-title":"Mol Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1172\/JCI129635","article-title":"Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation","volume":"130","author":"Ortiz-Mu\u00f1oz","year":"2020","journal-title":"J Clin Invest."},{"key":"B99","doi-asserted-by":"publisher","first-page":"105994","DOI":"10.1016\/j.rmed.2020.105994","article-title":"BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization","volume":"170","author":"Hovold","year":"2020","journal-title":"Respir Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"PA4532","DOI":"10.1183\/13993003.congress-2019.PA4532","article-title":"Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia","volume":"54","author":"Luquero-Bueno","year":"2019","journal-title":"Eur Respir J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/BF00263865","article-title":"Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a \u201cseverity of illness\u201d core","volume":"15","author":"Feldman","year":"1989","journal-title":"Intensive Care Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000195943","article-title":"Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit","volume":"58","author":"Feldman","year":"1991","journal-title":"Respiration."},{"key":"B103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jinf.2007.01.011","article-title":"Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia","volume":"55","author":"Brogly","year":"2007","journal-title":"J Infect."},{"key":"B104","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1378\/chest.09-0998","article-title":"Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia","volume":"137","author":"Mirsaeidi","year":"2010","journal-title":"Chest."},{"key":"B105","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ejcdt.2015.09.001","article-title":"Platelet count: Is it a possible marker for severity and outcome of community acquired pneumonia?","volume":"65","author":"ElMaraghy","year":"2016","journal-title":"Egypt J Chest Dis Tuberc."},{"key":"B106","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/09537104.2016.1219032","article-title":"Prognostic significance of platelet count changes during hospitalization for community-acquired pneumonia","volume":"28","author":"Gorelik","year":"2017","journal-title":"Platelets."},{"key":"B107","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1378\/chest.12-1235","article-title":"Thrombocytosis is a marker of poor outcome in community-acquired pneumonia","volume":"143","author":"Prina","year":"2013","journal-title":"Chest."},{"key":"B108","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejcdt.2012.10.030","article-title":"Thrombocytosis at time of hospitalization is a reliable indicator for severity of CAP patients in ICU","volume":"61","author":"Hesham","year":"2012","journal-title":"Egypt J Chest Dis Tuberc."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0208715","DOI":"10.1371\/journal.pone.0208715","article-title":"An increase in mean platelet volume during admission can predict the prognoses of patients with pneumonia in the intensive care unit: a retrospective study","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS ONE."},{"key":"B110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41983-018-0028-9","article-title":"Mean platelet volume to platelet count ratio as a laboratory indicator of mortality in pneumonia following ischemic stroke","volume":"54","author":"Nageeb","year":"2018","journal-title":"Egypt J Neurol Psychiatr Neurosurg."},{"key":"B111","doi-asserted-by":"publisher","first-page":"e01984","DOI":"10.1128\/mBio.01984-16","article-title":"Phage-derived protein induces increased platelet activation and is associated with mortality in patients with invasive pneumococcal disease","volume":"8","author":"Tunjungputri","year":"2017","journal-title":"MBio."},{"key":"B112","doi-asserted-by":"publisher","first-page":"PA2633","DOI":"10.1183\/13993003.congress-2018.PA2633","article-title":"Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days later","volume":"52","author":"M\u00e9ndez","year":"2018","journal-title":"Eur Respir J."},{"key":"B113","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1182\/blood.2019000067","article-title":"Sepsis alters the transcriptional and translational landscape of human and murine platelets","volume":"134","author":"Middleton","year":"2019","journal-title":"Blood."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.jacc.2014.07.985","article-title":"Platelet activation is associated with myocardial infarction in patients with pneumonia","volume":"64","author":"Cangemi","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/jth.14814","article-title":"Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae - the role of Fc\u03b3RIIa and platelet factor 4\/heparin antibodies","volume":"18","author":"Wolff","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B116","doi-asserted-by":"publisher","first-page":"13428","DOI":"10.1038\/s41598-018-31504-4","article-title":"High HMGB1 levels in sputum are related to pneumococcal bacteraemia but not to disease severity in community-acquired pneumonia","volume":"8","author":"Alpkvist","year":"2018","journal-title":"Sci Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cub.2006.01.056","article-title":"An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps","volume":"16","author":"Beiter","year":"2006","journal-title":"Curr Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1462-5822.2006.00857.x","article-title":"Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps","volume":"9","author":"Wartha","year":"2007","journal-title":"Cell Microbiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"103653","DOI":"10.1016\/j.micpath.2019.103653","article-title":"PspA facilitates evasion of pneumococci from bactericidal activity of neutrophil extracellular traps (NETs)","volume":"136","author":"Martinez","year":"2019","journal-title":"Microb Pathog."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.jacc.2014.08.023","article-title":"The sum of two evils: pneumonia and myocardial infarction: is platelet activation the missing link?","volume":"64","author":"Santos-Gallego","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.jacc.2014.11.073","article-title":"Platelets interplay between pneumonia and cardiovascular events: establishing a link?","volume":"65","author":"Gavriilaki","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jacc.2014.12.059","article-title":"Myocardial infarction in patients with pneumonia","volume":"65","author":"Savas","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jacc.2014.12.061","article-title":"Platelet activation and pneumonia: is soluble P-selectin the right marker?","volume":"65","author":"Gurbel","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.jacc.2014.12.057","article-title":"Reply: platelets interplay between pneumonia and cardiovascular events: establishing a link?","volume":"65","author":"Violi","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jacc.2014.12.060","article-title":"Reply: myocardial infarction in patients with pneumonia","volume":"65","author":"Violi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jacc.2015.02.011","article-title":"Reply: platelet activation and pneumonia. Is soluble P-selectin the right marker?","volume":"65","author":"Violi","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jacc.2014.12.058","article-title":"Reply: platelet interplay between pneumonia and cardiovascular events. Establishing a link?","volume":"65","author":"Santos-Gallego","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jacc.2014.11.074","article-title":"Platelet activation and myocardial infarction in patients with pneumonia: are statins the answer?","volume":"65","author":"Khan","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e001595","DOI":"10.1161\/JAHA.114.001595","article-title":"Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin","volume":"4","author":"Falcone","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"B130","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00134-015-4139-9","article-title":"Septic shock from community-onset pneumonia: is there a role for aspirin plus macrolides combination?","volume":"42","author":"Falcone","year":"2016","journal-title":"Intensive Care Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00408-016-9900-5","article-title":"Pneumolysin mediates platelet activation in vitro","volume":"194","author":"Nel","year":"2016","journal-title":"Lung."},{"key":"B132","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/cei.12766","article-title":"Pneumolysin activates neutrophil extracellular trap formation","volume":"184","author":"Nel","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jinf.2017.02.010","article-title":"Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro","volume":"74","author":"Nel","year":"2017","journal-title":"J Infect."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood."},{"key":"B135","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fimmu.2016.00236","article-title":"The emerging role of NETs in venous thrombosis and immunothrombosis","volume":"7","author":"Kimball","year":"2016","journal-title":"Front Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/antiox7070083","article-title":"Interplay between oxidative stress and platelet activation in coronary thrombus of STEMI patients","volume":"7","author":"Calvieri","year":"2018","journal-title":"Antioxidants."},{"key":"B137","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jama.2016.0136","article-title":"Histone-associated thrombocytopenia in patients who are critically ill","volume":"315","author":"Alhamdi","year":"2016","journal-title":"JAMA."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1182\/blood-2011-01-332676","article-title":"Histones induce rapid and profound thrombocytopenia in mice","volume":"118","author":"Fuchs","year":"2011","journal-title":"Blood."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1701389","DOI":"10.1183\/13993003.01389-2017","article-title":"Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial","volume":"51","author":"Ebrahimi","year":"2018","journal-title":"Eur Respir J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41564-018-0280-x","article-title":"Pneumolysin binds to the Mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival","volume":"4","author":"Subramanian","year":"2019","journal-title":"Nat Microbiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jinf.2012.09.003","article-title":"Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia","volume":"66","author":"Viasus","year":"2013","journal-title":"J Infect."},{"key":"B142","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1164\/rccm.201707-1421ED","article-title":"Pneumonia and the risk of cardiovascular death. Time to change our strategy","volume":"196","author":"Welte","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.111.040766","article-title":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","volume":"125","author":"Corrales-Medina","year":"2012","journal-title":"Circulation."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e1125","DOI":"10.1016\/j.ijid.2013.07.005","article-title":"Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia","volume":"17","author":"Griffin","year":"2013","journal-title":"Int J Infect Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.12688\/f1000research.14226.1","article-title":"Appropriate antibiotic management of bacterial lower respiratory tract infections","volume":"7","author":"Feldman","year":"2018","journal-title":"F1000Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/14787210.2018.1512403","article-title":"Severe community-acquired pneumonia: current management and future therapeutic alternatives","volume":"16","author":"Garnacho-Montero","year":"2018","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B147","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5492\/wjccm.v8.i5.74","article-title":"Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers","volume":"8","author":"Chalmers","year":"2019","journal-title":"World J Crit Care Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/ph3051694","article-title":"Beneficial and harmful interactions of antibiotics with microbial pathogens and the host innate immune system","volume":"3","author":"Anderson","year":"2010","journal-title":"Pharmaceuticals."},{"key":"B149","doi-asserted-by":"publisher","first-page":"584262","DOI":"10.1155\/2012\/584262","article-title":"Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics","volume":"2012","author":"Steel","year":"2012","journal-title":"Mediat Inflamm."},{"key":"B150","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","article-title":"The immunomodulatory effects of macrolides - a systematic review of the underlying mechanism","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Front Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2213-2600(20)30080-1","article-title":"Immunomodulation by macrolides: therapeutic potential for critical care","volume":"8","author":"Reijnders","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/23744235.2017.1350881","article-title":"The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization","volume":"50","author":"Peyrani","year":"2018","journal-title":"Infect Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-9255-8-17","article-title":"In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards platelet activating factor and thrombin","volume":"8","author":"Tsoupras","year":"2011","journal-title":"J Inflamm."},{"key":"B154","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/MCA.0b013e32835d7610","article-title":"Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial","volume":"24","author":"Oz","year":"2013","journal-title":"Coron Artery Dis."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e01556","DOI":"10.1128\/AAC.01556-18","article-title":"A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia","volume":"63","author":"Falcone","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B156","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1164\/rccm.201802-0229LE","article-title":"Nonsteroidal antiinflammatory drug use and clinical outcomes of community-acquired pneumonia","volume":"198","author":"Basille","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"CD007720","DOI":"10.1002\/14651858.CD007720.pub3","article-title":"Corticosteroids for pneumonia","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B158","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ajem.2017.07.050","article-title":"Efficacy of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis","volume":"36","author":"Wu","year":"2018","journal-title":"Am J Emerg Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e16239","DOI":"10.1097\/MD.0000000000016239","article-title":"Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine."},{"key":"B160","doi-asserted-by":"publisher","first-page":"e14636","DOI":"10.1097\/MD.0000000000014636","article-title":"Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: a systematic review and meta-analysis","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.bcp.2012.02.006","article-title":"Prednisolone exerts exquisite inhibitory properties on platelet functions","volume":"83","author":"Liverani","year":"2012","journal-title":"Biochem Pharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.phrs.2018.03.014","article-title":"Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia","volume":"131","author":"Cangemi","year":"2018","journal-title":"Pharmacol Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1513\/AnnalsATS.201806-419OC","article-title":"Corticosteroids use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia","volume":"16","author":"Cangemi","year":"2019","journal-title":"Ann Am Thorac Soc."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.chest.2019.06.017","article-title":"Corticosteroids for community-acquired pneumonia: overstated benefits and understated risks","volume":"156","author":"Waterer","year":"2019","journal-title":"Chest."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jamainternmed.2019.1438","article-title":"Effectiveness of the bundled intervention including adjunctive corticosteroids on outcomes of hospitalized patients with community-acquired pneumonia. A stepped-wedged randomized clinical trial","volume":"179","author":"Lloyd","year":"2019","journal-title":"JAMA Intern Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11739-019-02117-0","article-title":"Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial","volume":"15","author":"Violi","year":"2020","journal-title":"Intern Emerg Med."},{"key":"B167","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B168","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40262-020-00864-4","article-title":"Pharmacokinetics and pharmacodynamics of approved and investigational P2Y12 receptor antagonists","volume":"59","author":"Schilling","year":"2020","journal-title":"Clin Pharmacokinet."},{"key":"B169","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11239-012-0833-4","article-title":"Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness","volume":"35","author":"Gross","year":"2013","journal-title":"J Thromb Thrombolysis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets."},{"key":"B172","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jacbts.2018.05.005","article-title":"Ticagrelor reduces thromboinflammatory markers in patients with pneumonia","volume":"3","author":"Sexton","year":"2018","journal-title":"JACC Basic Transl Sci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1378\/chest.15-0484","article-title":"Community-acquired pneumonia: pathogenesis of acute cardiac events and potential adjunctive therapies","volume":"148","author":"Feldman","year":"2015","journal-title":"Chest."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1124\/jpet.107.122853","article-title":"Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling","volume":"322","author":"Marwali","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm1626","article-title":"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype","volume":"13","author":"Podrez","year":"2007","journal-title":"Nat Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12265-013-9529-1","article-title":"Antiplatelet therapy: targeting the TxA2 pathway","volume":"7","author":"Fontana","year":"2014","journal-title":"J Cardiovasc Transl Res."},{"key":"B177","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-051812-145304","article-title":"The antithrombotic effects of statins","volume":"65","author":"Owens","year":"2014","journal-title":"Annu Rev Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/000456329703400308","article-title":"Effect of simvastatin therapy on cell membrane cholesterol content and membrane function as assessed by polymorphonuclear cell NADPH oxidase activity","volume":"34","author":"Day","year":"1997","journal-title":"Ann Clin Biochem."},{"key":"B179","doi-asserted-by":"publisher","first-page":"6508709","DOI":"10.1155\/2018\/6508709","article-title":"Simvastatin effects on inflammation and platelet activation markers in hypercholesterolemia","volume":"2018","author":"Barale","year":"2018","journal-title":"Biomed Res Int."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1164\/rccm.201812-2328OC","article-title":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial","volume":"200","author":"Sapey","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nbt.3037","article-title":"Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice","volume":"33","author":"Henry","year":"2015","journal-title":"Nat Biotechnol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1473-3099(18)30805-3","article-title":"CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial","volume":"19","author":"Laterre","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B183","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2018.03.014","article-title":"Diverse signalling of the platelet P2Y1 receptor leads to a dichotomy in platelet function","volume":"827","author":"Amison","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting inflammation driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol."},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa295","article-title":"Necroptosis inhibition prevents long-term cardiac damage during pneumococcal pneumonia and invasive disease","author":"Beno","year":"2020","journal-title":"J Infect Dis"},{"key":"B186","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2147\/OTT.S189391","article-title":"Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies","volume":"12","author":"Tan","year":"2019","journal-title":"Onco Targets Ther."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.577303\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T06:57:51Z","timestamp":1600325871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.577303\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":186,"alternative-id":["10.3389\/fimmu.2020.577303"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.577303","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"article-number":"577303"}}